Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av platformen MFN för nyhetsdistribution?

Söndag 30 Augusti | 08:25:46 Europe / Stockholm

Svenska | English

Analyst Group

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Analyst Group Interview Nykode Therapeutics' CEO Michael Engsig

2026-08-27 14:54:00

We have interviewed Michael Engsig, CEO of Nykode Therapeutics. In the interview Michael tell us where the company is today, the strategy going forward and why the company is a good investment.

Read the interview here

About Analyst Group: One of the Nordics fastest growing equity research boutiques with a focus on small and medium-sized listed companies.
Read more about Analyst Group (Swedish)

This is a press release from Analyst Group regarding the publication of an interview with Nykode Therapeutics.